Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Atlantic Pharmaceuticals has received two new US Patent and Trademark Office (USPTO) patents for its tamper-resistant SMART/Script drug delivery platform.
Subscribe to our email newsletter
The patents cover company’s tamper-resistant platforms, designed to resist dose dumping of orally delivered opioids and may sequester and bring down drug release of a drug, which has been subjected to a variety of physical methods of tampering.
The technology can be used to both, immediate as well as sustained release drug candidates.
Atlantic Pharmaceuticals president Anthony Soscia said the SMART/Script is a technology that may have a significant effect on prescription drug abuse and misuse.
"These patents further add to our intellectual property portfolio and provide us with extensive coverage until 2028 for our novel, tamper-resistant technology,"Soscia added.
SMART/Script, a patented drug delivery platform stops drug extraction and avoids the abuse of medications through known routes of abuse, including chewing, snorting and injecting.